CIK 0001395064
- Large accelerated filer
TAKEDA PHARMACEUTICAL CO LTD
Sign in to watch- Ticker
- TKPHF
- Exchange
- NYSE, OTC
- Industry
- Pharmaceutical Preparations
- Entity type
- Other
- Phone
- +81 332782111
- Business address
- 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU, TOKYO, Japan, 103-8668
Securities
- TAK Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) NYSE
- TKPHF Common stock OTC
- 4 Grant or award Pres., Global Supply & Quality acquired 30,094 shares (grant or award)
- 4 Grant or award Chief Transformation Officer acquired 45,140 shares (grant or award)
- 4 Grant or award President, OBU acquired 43,886 shares (grant or award)
- 4 Grant or award President and CEO acquired 73,234 shares (grant or award)
- 4 Grant or award President, R&D acquired 125,390 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Grant or award President and CEO acquired 244,270 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 7,800 shares (grant or award)
- 4 Grant or award President, R&D acquired 212,470 shares (grant or award)
- 4 Grant or award Chief Data & Tech. Officer acquired 34,994 shares (grant or award)
- 4 Grant or award President, OBU acquired 64,988 shares (grant or award)
- 4 Grant or award Chief Transformation Officer acquired 59,990 shares (grant or award)
- 4 Grant or award CEO - Elect acquired 105,416 shares (grant or award)
- 4 Grant or award President, IBU acquired 72,124 shares (grant or award)
- 4 Grant or award Head, Strat. & Port. Dev. acquired 27,740 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 3 of 7 · 137 filings